Boston University News Releases

Regenerative medicine: the future of organ donation?

Jackie Rubin — 2012-02-03T10:43:25-05:00

As we face a severe and worsening shortage of donor organs, Dr. Anthony Atala says we should look to a new approach: regenerative medicine.

BOSTON MEDICAL CENTER DOCTOR NAMED A CMS INNOVATION ADVISOR TO IMPROVE PATIENT CARE

Gina M. Digravio — 2012-01-09T10:23:04-05:00

(Boston) - Winnie Suen, MD, MSc, a geriatrician and palliative care consultant at Boston Medical Center (BMC) and assistant professor of medicine at Boston University School of Medicine (BUSM), has been selected as a member of the Centers for Medicare and Medicaid Services’ (CMS) Innovation Advisors Program. The initiative, launched by the CMS Innovation Center, will help health professionals deepen or sharpen skills that drive improvements to patient care and reduce costs.

Study Finds Air Pollution Linked to Increased Incidence of Diabetes and Hypertension in African American Women

Gina M. Digravio — 2012-01-05T13:44:42-05:00

(Boston) - The incidence of type 2 diabetes and hypertension increases with cumulative levels of exposure to nitrogen oxides, according to a new study led by researchers from the Slone Epidemiology Center (SEC) at Boston University. The study, which appears online in the journal Circulation, was led by Patricia Coogan, D.Sc., associate professor of epidemiology at the Boston University School of Public Health and the SEC.

Study Finds Statin Costs 400 Percent Higher In US Compared To UK

Gina M. Digravio — 2012-01-05T09:44:58-05:00

(Boston) -- In the United States, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who have private insurance is approximately 400 percent higher than comparable costs paid by the government in the United Kingdom (U.K.). These findings, from the Boston University School of Medicine (BUSM) Boston Collaborative Drug Surveillance Program, are the first results of a comprehensive comparison of prescription drug costs between the U.S. and U.K. The study appears in The Jan. 2012 issue of the journal Pharmacotherapy.

BUSM Researchers Identify Novel Compound to Halt Virus Replication

Jenny Eriksen — 2012-01-03T12:15:18-05:00

(Boston) – A team of scientists from Boston University School of Medicine (BUSM) have identified a novel compound that inhibits viruses from replicating. The findings, which are published online in the Journal of Virology, could lead to the development of highly targeted compounds to block the replication of poxviruses, such as the emerging infectious disease Monkeypox.